When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Infarto de miocardio sin elevación del segmento ST

Última revisión: 21 Oct 2024
Última actualización: 25 Jul 2023

Resumen

Definición

Anamnesis y examen

Principales factores de diagnóstico

  • presencia de factores de riesgo
  • dolor torácico
  • diaforesis
Todos los datos

Otros factores de diagnóstico

  • disnea
  • debilidad
  • ansiedad
  • náuseas y vómitos
  • dolor abdominal
  • hipertensión
  • presentación temprano en la mañana
  • síncope
  • hipotensión
  • arritmias
  • ruido cardíaco anormal
Todos los datos

Factores de riesgo

  • aterosclerosis (antecedentes de angina, infarto de miocardio, accidente cerebrovascular, accidente isquémico transitorio, enfermedad vascular periférica)
  • diabetes
  • tabaquismo
  • dislipidemia
  • antecedentes familiares de arteriopatía coronaria (AC) prematura
  • edad >65 años
  • hipertensión
  • obesidad y fenotipo del síndrome metabólico
  • inactividad física
  • consumo de cocaína
  • depresión
  • trombosis del stent o reestenosis
  • enfermedad renal crónica
  • procedimientos quirúrgicos (incluidos períodos intraoperativos y postoperativos)
  • apnea del sueño
Todos los datos

Pruebas diagnósticas

Primeras pruebas diagnósticas para solicitar

  • electrocardiograma (ECG)
  • biomarcadores cardíacos
  • ecocardiografía
  • hemograma completo (HC)
  • urea y creatinina sérica
  • electrolitos
  • pruebas de función hepática (PFH)
  • glucemia
  • radiografía de tórax
Todos los datos

Pruebas diagnósticas que deben considerarse

  • lípidos
  • péptido natriurético cerebral (PNC) o N-terminal pro-PNC (NT-pro-PNC)
  • angiografía/cateterismo cardíaco
  • pruebas de esfuerzo
  • angiografía coronaria por tomografía computarizada (ACTC)
Todos los datos

Algoritmo de tratamiento

Agudo

presentación aguda

En curso

después de la estabilización

Colaboradores

Autores

Mahi L. Ashwath, MD, MBA, FACC, FASE, FSCMR

Director, Cardiac MRI

Clinical Professor of Medicine and Radiology

Division of Cardiology

Department of Internal Medicine

University of Iowa Hospitals and Clinics

University of Iowa Health Care

Iowa

IA

Divulgaciones

MLA declares that she is a member of the Board of Governors of the American College of Cardiology.

Sanjay Gandhi, MD, MBA, FACC, FAHA, FSCAI

Director, Endovascular Cardiology

Professor of Medicine, Endovascular Cardiology

Case Western Reserve University

Cleveland

OH

Divulgaciones

SG declares that he is Senior Director of Medical Strategy and Innovation for the US market at Philips. SG is a senior advisor at Emeritus. SG is a voluntary board member of the American College of Cardiology (ACC) National Cardiovascular Data Registry oversight committee, the Chest Pain Myocardial Infarction registry steering committee, and the ACC finance committee.

Agradecimientos

Dr Mahi L. Ashwath and Dr Sanjay Gandhi would like to gratefully acknowledge Dr Cody Deen, Dr Sripal Bangalore, Dr Mina Owlia, Dr Thomas Vanhecke, and Dr Dena Krishnan, the previous contributors to this topic.

Divulgaciones

CSD was previously the Director of Cardiac Rehab for Chatham Hospital, which was financially set up as a consultancy relationship, until 2017. CSD has spoken (unpaid) at the Update in Cardiology and Update in Internal Medicine Conferences at UNC for the last 5 years. CSD has served as the PI for the Dal-GeneE (site now closed) and the ACCELERATE Trials at the University of North Carolina (trial now completed). Each trial required paid travel to an investigator meeting. SB, MO, TV, and DK declare that they have no competing interests.

Revisores por pares

Syed Wamique Yusuf, MBBS, FRCPI

Professor of Medicine

Department of Cardiology

University of Texas

MD Anderson Cancer Center

Houston

TX

Divulgaciones

SWY declares that he has no competing interests.

El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad